RNA-Seq – Products

Understanding the mechanisms of human disease requires a multiomic approach; however, legacy multiomic methods require multiple platforms and complex processes with lengthy turnaround times and considerable costs.

This application note explores an optimized RNA-sequencing workflow that reliably determines cell subset abundance and cell-type-specific gene expression profiles from bulk tissue or blood expression data.

This application note explores the performance characteristics of a tissue panel for profiling both FF and FFPE tissue samples using a state-of-the-art software solution for digital cytometry.

Curio Bioscience licenses a novel method from the Broad Institute of MIT and Harvard to fuel the next generation of discovery research.

This app note highlights a convenient, efficient and reliable workflow for massively multiplexed RNA-seq experiments.

This application note presents capture sequencing using a novel RNA exome panel as a powerful approach to specifically target the transcriptome to profile gene expression and discover novel fusion genes.

Due to the sheer number of possible compounds available, pharmaceutical companies have been adopting high-throughput screening (HTS) methods that can screen chemical libraries rapidly and inexpensively to identify the most promising compounds with activity against a specific biological target.

Company announces roadmap anchored by new two plate workflow enabling preparation of samples up to 2 million cells and beyond. New collaborations with Vizgen, BioLegend, and SPT Labtech will extend range.

This application note highlights how clinical scientists optimized genomics testing methods to attain reliable fusion data from FFPE samples.

AMSBIO announce the launch of a custom service providing access to a suite of powerful spatial biology multi-omics profiling tools.